All News

A large coalition of medical associations, patient advocacy groups, drug companies, and others sent a letter to Congress Monday asking that they intervene on a CMS plan to use an index based on drug prices in other countries to determine reimbursement for Part B therapies, saying it would have a negative effect on the elderly and people with disabilities.

Battle lines are being drawn between establishment Democrats and progressive liberals in Congress over the idea of single-payer healthcare; an antitrust lawsuit filed in 2016 by states over 2 generic drugs has expanded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs; HHS will consider whether to approve work requirements for Medicaid expansion in Virginia.

Patients who visit the emergency department for pain are often asked to categorize their pain level using a visual scale of numbered faces. However, a recent study suggests the efficacy of a more empirical approach, through the use of an electroencephalography (EEG)-based test, that would be beneficial for both patients and physicians.

An investigation in South Dakata has found that dozens of patients have died needlessly due to errors made in Indian Health Service (HIS) facilties in the state; a recent case of a Michigan woman resorting to crowdfunding to pay for post-transplant care in order to get on an organ transplant list sparked outrage, but requiring proof of payment for organ transplants and post-operative care is common; a judge in Maine denied a request by the outgoing GOP Governor Paul LePage to stay an order that the state implement Medicaid expansion, which was approved by voters last year.

This week, the top managed care news included a CDC report that found life expectancy in the United States declined again; telemedicine use among physicians remains low; another study added to the debate over who should take statins.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text